Your browser doesn't support javascript.
loading
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
Fujita, Wakako; Gomes, Ivone; Dove, Leonard S; Prohaska, David; McIntyre, Gail; Devi, Lakshmi A.
Afiliação
  • Fujita W; Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gomes I; Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Dove LS; Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560, USA.
  • Prohaska D; Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560, USA.
  • McIntyre G; Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560, USA.
  • Devi LA; Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Lakshmi.devi@mssm.edu.
Biochem Pharmacol ; 92(3): 448-56, 2014 Dec 01.
Article em En | MEDLINE | ID: mdl-25261794
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenilalanina / Receptores Opioides delta / Receptores Opioides mu / Diarreia / Imidazóis Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenilalanina / Receptores Opioides delta / Receptores Opioides mu / Diarreia / Imidazóis Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article